Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014

Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl

Am J Cardiol.

Piao ZH, Jin L, Kim JH, Ahn Y, Kim YJ, Cho MC, Kim CJ, Kim HS, Liu B, Jeong MH; Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators

doi: 10.1016/j.amjcard.

COMMENTED

Diabetes - GeneralLipids

Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014)

Circulation.

Bucholz EM, Rodday AM, Kolor K, Khoury MJ, de Ferranti SD

doi: 10.1161/CIRCULATIONAHA.

Diabetes - General

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort

J Diabetes.

Zhang N, Hu X, Zhang Q, Bai P, Cai M, Zeng TS, Zhang JY, Tian SH, Min J, Huang HT, Zheng J, Peng MM, Li MJ, Chen LL

doi: 10.1111/1753-0407.12650.

Pediatric Diabetes

The Association of Low-Density Lipoprotein Cholesterol with Elevated Arterial Stiffness in Adolescents and Young Adults with type 1 and type 2 Diabetes: The SEARCH for Diabetes in Youth Study

Pediatr Diabetes.

Gourgari E, Stafford JM, D'Agostino R Jr, Dolan LM, Lawrence JM, Marcovina S, Merjaneh L, Mottl AK, Shah AS, Dabelea D

doi: 10.1111/pedi.13021.

COMMENTED

Type 2 Diabetes

Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)

Circulation.

Arnold SV, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE, Alam S, Elliott-Davey M, Bhatt DL, Cannon CP, Kosiborod M, GOULD Investigators.

doi: 10.1161/

COMMENTED

Lipids

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

Lancet.

Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, Schwartz GG, Olsson AG, Colhoun HM, Kronenberg F, Drechsler C, Wanner C, Mora S, Lesogor A, Tsimikas S

doi: 10.1016/S0140-

COMMENTED

Type 2 Diabetes

Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

JAMA Cardiol.

Lotta LA, Stewart ID, Sharp SJ, Day FR, Burgess S, Luan J, Bowker N, Cai L, Li C, Wittemans LBL, Kerrison ND, Khaw KT, McCarthy MI, O'Rahilly S, Scott RA, Savage DB, Perry JRB, Langenberg C, Wareham NJ

doi: 10.1001/jamacardio.

COMMENTED

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Circulation.

Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS

doi: 10.1161/CIRCULATIONAHA.

Diabetes - GeneralType 2 Diabetes

Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis

JAMA.

Lotta LA, Sharp SJ, Burgess S, Perry JR, Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B, Boeing H, Deloukas P, Forouhi NG, Franks PW, Grioni S, Kaaks R, Key TJ, Navarro C, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Riboli E, Rolandsson O, Sacerdote C, Salamanca-Fernandez E, Slimani N, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, McCarthy MI, Barroso I, O'Rahilly S, Savage DB, Sattar N, Langenberg C, Scott RA, Wareham NJ

doi: 10.1001/jama.2016.14568.

Related content

Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl

Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014)

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort

The Association of Low-Density Lipoprotein Cholesterol with Elevated Arterial Stiffness in Adolescents and Young Adults with type 1 and type 2 Diabetes: The SEARCH for Diabetes in Youth Study

Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis